Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 4Neoplasm Metastasis 2Lung Neoplasms 2Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Adenocarcinoma of Lung 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nausea 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Endometrial Serous Adenocarcinoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Endometrial Serous Adenocarcinoma × Radiotherapy, Conformal × Clear all
NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
4 enrolled 6 charts
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡